Literature DB >> 16236060

Peripheral regulatory mechanisms in erection.

A Morelli1, S Filippi, X-H Zhang, M Luconi, L Vignozzi, R Mancina, M Maggi.   

Abstract

The most important pathway underlying the penile erection is the nonadrenergic/noncholinergic signalling, which through the release of nitric oxide (NO), leads to an intracellular increase of cyclic GMP (cGMP), the main secondary messenger mediating tumescence in the penis. Interestingly, both cGMP formation and degradation are affected by testosterone (T). In fact, beyond the well-known role of T in regulating sexual desire and NO release, recent experimental evidences from our group showed that T also regulates the expression of phosphodiesterase type 5 (PDE5), the hydrolytic enzyme involved in cGMP breakdown. This antithetic role of T seems to be the main way through which the peripheral hormonal regulation of penile erections occurs, allowing an important synchronization between erectile processes and sexual desire. Hence, erections are still possible in hypogonadal conditions where a decreased cGMP formation, because of impaired NO production, is counterbalanced by a reduced cGMP hydrolysis. The purpose of this review is to describe evidences about the peripheral role of T in regulating penile erection and to justify the importance to test T plasma levels in those patients with erectile dysfunction who do not respond to PDE5 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16236060     DOI: 10.1111/j.1365-2605.2005.00550.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  13 in total

Review 1.  Testosterone therapy improves erectile function and libido in hypogonadal men.

Authors:  Paul J Rizk; Taylor P Kohn; Alexander W Pastuszak; Mohit Khera
Journal:  Curr Opin Urol       Date:  2017-11       Impact factor: 2.309

Review 2.  Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction.

Authors:  Abdulmaged M Traish; Irwin Goldstein; Noel N Kim
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

3.  Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?

Authors:  Antonio Aversa; Roberto Bruzziches; Davide Francomano; Marco Natali; Andrea Lenzi
Journal:  Ther Adv Urol       Date:  2009-10

Review 4.  The use of phosphodiesterase 5 inhibitors with concomitant medications.

Authors:  G Corona; E Razzoli; G Forti; M Maggi
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

Review 5.  Which patients with sexual dysfunction are suitable for testosterone replacement therapy?

Authors:  A Morelli; G Corona; S Filippi; S Ambrosini; G Forti; L Vignozzi; M Maggi
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

6.  Erectile dysfunction in a murine model of sleep apnea.

Authors:  Galia K Soukhova-O'Hare; Zahoor A Shah; Zhenmin Lei; Alexander D Nozdrachev; C Venkateswara Rao; David Gozal
Journal:  Am J Respir Crit Care Med       Date:  2008-06-05       Impact factor: 21.405

7.  Testosterone regulates erectile function and Vcsa1 expression in the corpora of rats.

Authors:  Rowena G Chua; Giulia Calenda; Xinhua Zhang; Joseph Siragusa; Yuehong Tong; Moses Tar; Memduh Aydin; Michael E DiSanto; Arnold Melman; Kelvin P Davies
Journal:  Mol Cell Endocrinol       Date:  2009-02-13       Impact factor: 4.102

Review 8.  The many faces of testosterone.

Authors:  Jerald Bain
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

9.  Markers of erectile dysfunction.

Authors:  Kelvin P Davies; Arnold Melman
Journal:  Indian J Urol       Date:  2008-07

10.  Testosterone regulates the expression and functional activity of sphingosine-1-phosphate receptors in the rat corpus cavernosum.

Authors:  Jing Yin; Yu-Ming Guo; Ping Chen; He Xiao; Xing-Huan Wang; Michael E DiSanto; Xin-Hua Zhang
Journal:  J Cell Mol Med       Date:  2017-12-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.